BioCentury
ARTICLE | Financial News

ABL snags $65M in series C

June 15, 2018 8:14 PM UTC

ABL Bio Inc. (Seongnam, South Korea) raised $65 million on June 8 in a series C round led by new investors DS Asset Management, Alpen Route Asset Management, Quad Asset Management and Hana Financial Investment.

ABL has now raised over $93 million since its founding in 2016. The Korean company plans to go public this year or next...